Vitamin E analogs: A new class of multiple action agents with anti-neoplastic and anti-atherogenic activity

Apoptosis

Volumn 7, Issue 2, 2002, Pages 179-187

  Neuzil, J ^a,b,c   Kagedal K ^a   Andera, L ^d   Weber, C ^b,e   Brunk, U T ^a  

^a LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF MUNICH   (Germany)

^c GRIFFITH UNIVERSITY   (Australia)

^d INSTITUTE OF MOLECULAR GENETICS   (Czech Republic)

^e UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

Apoptosis; Atherosclerosis; Cancer therapy; Provitamin; Vitamin E succinate

Indexed keywords

ALPHA TOCOPHEROL DERIVATIVE; ALPHA TOCOPHEROL SUCCINATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CANCER INCIDENCE; CANCER INHIBITION; CAUSE OF DEATH; CONTROLLED STUDY; DEVELOPED COUNTRY; DRUG MECHANISM; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTICHOLESTEREMIC AGENTS; ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; APOPTOSIS REGULATORY PROTEINS; MEMBRANE GLYCOPROTEINS; MICE; MODELS, BIOLOGICAL; NEOPLASMS; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR NECROSIS FACTOR-ALPHA; VITAMIN E;

ANIMALIA;

EID: 0036204019     PISSN: 13608185     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1014378901843     Document Type: Article

References (67)

1. Vitamin E: Antioxidant activity, biokinetics, and bioavailability
2. Induction of apoptosis in cancer cells by α-tocopheryl succinate: Molecular pathways and structural requirements
3. The selective antiproliferative effects of α-tocopheryl hemisuccinate and cholesteryl hemisuccinate on murine leukemia cells result from the action of the intact compounds
4. Growth inhibition and apoptosis of RL human B lymphoma cells by vitamin E succinate and retinoic acid: Role for transforming growth factor-β
5. c-Jun involvement in vitamin E succinate induced apoptosis of reticuloendotheliosis virus transformed avian lymphoid cells
6. Lipoprotein-associated α-tocopheryl-succinate inhibits cell growth and induces apoptosis in human MCF-7 and HBL-100 breast cancer cells
7. Selective cancer cell killing by α-tocopheryl succinate
8. Administration of the tris salt of α-tocopheryl hemisuccinate inactivates CYP2E1, enhances microsomal α-tocopherol levels and protects against carbon tetrachloride-induced hepatotoxicity
9. Processing of vitamin A and E in the human gastrointestinal tract
10. Absorption, lipoprotein transport, and regulation of plasma concentrations of vitamin E in humans
11. Protection against carbon tetrachloride-induced hepatotoxicity by pretreating rats with the hemisuccinate esters of tocopherol and cholesterol
12. Vitamin E: Application of the principles of physical organic chemistry to the exploration of its structure and function
13. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity
14. Atherosclerosis - An inflammatory disease
15. Requirement for, promotion, or inhibition by α-tocopherol of radical-induced initiation of plasma lipoprotein lipid peroxidation
16. Vitamin E: Non-antioxidant roles
17. Vitamin E in atherosclerosis: Linking the chemical, biological and clinical aspects of the disease
18. Oxidants and antioxidants in the pathogenesis of atherosclerosis: Implications for the oxidized low density lipoprotein hypothesis
19. Coexistence of oxidized lipids and α-tocopherol in all lipoprotein density fractions isolated from advanced human atherosclerotic plaques
20. Co-supplementation with ubiquinone-10 inhibits the pro-oxidant activity of α-tocopherol in transition metal-mediated oxidation of isolated low-density lipoprotein
21. α-tocopheryl hydroquinone is an efficient multi-functional inhibitor of radical-initiated oxidation of low-density lipoprotein lipids
22. Vitamin E and vascular homeostasis: Implications for atherosclerosis
23. The effects of α-tocopherol on critical cells in atherogenesis
24. Nuclear factor-κB: A pivotal transcription factor in chronic inflammatory diseases
25. Antioxidant and redox regulation of gene transcription
26. α-tocopherol inhibits agonist-induced monocytic cell adhesion to cultured human endothelial cells
27. The effects of α-tocopherol supplementation on monocyte function. Decreased lipid oxidation, interleukin 1-β secretion, and monocyte adhesion to endothelium
28. Vitamin E reduces the uptake of oxidized LDL by inhibiting CD36 scavenger receptor expression in cultured aortic smooth muscle cells
29. Inhibition of inflammatory endothelial responses by a pathway involving caspase activation and p65 cleavage
30. α-tocopheryl succinate inhibits monocytic cell adhesion to endothelial cells by suppressing NF-κB mobilization
31. Apoptosis overrides survival signals through a caspase-mediated dominant-negative NF-κB loop
32. Vitamin E suppresses isoprostane generation in vivo and reduces atherosclerosis in apoE-deficient mice
33. Reduction of isoprostanes and regression of advanced atherosclerosis by apolipoprotein E
34. Increased atherosclerosis in hyperlipidemic mice deficient in α-tocopherol transfer protein and vitamin E
35. Dietary cosupplementation with vitamin E and coenzyme Q-10 inhibits atherosclerosis in apolipoprotein E gene knockout mice
36. Vitamin E and heart disease: Basic science to clinical intervention trials
37. α-tocopheryl succinate-induced apoptosis in Jurkat T cells involves caspase-3 activation, and both lysosomal and mitochondrial destabilisation
38. α-tocopheryl succinate, an agent with in vivo anti-tumour activity, induces apoptosis by causing lysosome instability
39. Mitochondria: Execution central
40. The role of lysosomes in apoptosis
41. Cathepsin D protease mediates programmed cell death induced by interferon-γ, Fas/PO-1 1996 and TNFα
42. Cathepsin B contributes to TNF-α-mediated hepatocyte apoptosis by promoting mitochondrial release of cytochrome c
43. Lysosomal destabilization during macrophage damage induced by cholesterol oxidation products
44. Oxidative stress causes relocation of the lysosomal enzyme cathepsin D with ensuing apoptosis in neonatal rat cardiomyocytes
45. Lysosomal release of cathepsin D precedes relocation of cytocrome c and loss of mitochondrial transmembrane potential during apoptosis induced by oxidative stress
46. The lysosomal protease cathepsin D mediates apoptosis induced by oxidative stress
47. Caspase-3 activation by lysosomal enzymes in cytochrome c-independent apoptosis in myelodysplastic syndrome-derived cell line P39
48. Lysosomal protease pathways to apoptosis. Cleavage of Bid, not pro-caspases, is the most likely route
49. Potential role for cathepsin D in p53-dependent tumor suppression and chemosensitivity
50. Mechanism of α-tocopheryl succinate-induced apoptosis of promyelocytic leukemia cells
51. Vitamin E analogs as inducers of apoptosis: Application for potential cancer treatment
52. Vitamin E succinate inhibits proliferation of BT-20 human breast cancer cells: Increased binding of cyclin A negatively regulates E2F transactivation activity
53. Protection of zidovudine-induced toxicity against murine erythroid progenitor cells by vitamin E
54. Vitamin E succinate is a potent novel anti-neoplastic agent with high tumor selectivity and cooperativity with TRAIL in vivo
55. Vitamin E succinate promotes breast cancer tumor dormancy
56. Effects of supplemental α-tocopherol and β-carotene on colorectal cancer: Results from a controlled trial
57. Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo
58. The TRAIL to selective tumor death
59. Selectivity of TRAIL-mediated apoptosis of cancer cells and synergy with drugs: The trail to non-toxic cancer therapeutics
60. The potential of TRAIL for cancer chemotherapy
61. Pretreatment with paclitaxel enhances apo-2 ligand/tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of prostate cancer cells by inducing death receptors 4 and 5 protein levels
62. Increased death receptor 5 expression by chemotherapeutic agents in human gliomas causes synergistic cytotoxicity with tumor necrosis factor-related apoptosis-inducing ligand in vitro and in vivo
63. Chemotherapy augments TRAIL-induced apoptosis in breast cell lines
64. Combined effect of tumor necrosis factor-related apoptosis-inducing ligand and ionizing radiation in breast cancer therapy
65. Biokinetics in humans of R R R-α-tocopherol: The free phenol, acetate ester, and succinate ester forms of vitamin E
66. γ-tocopherol and its major metabolite, in contrast to α-tocopherol, inhibit cyclooxygenase activity in macrophages and epithelial cells
67. Human plasma vitamin E kinetics demonstrate rapid recycling of plasma R R R-α-tocopherol